Covington & Burling LLP

From our offices in Beijing, Brussels, Dubai, Frankfurt, Johannesburg, London, Los Angeles, New York, Palo Alto, San Francisco, Seoul, Shanghai, and Washington, we practice as one firm, holding closely to core values that start with a deep commitment to our clients and the quality of our work on their behalf, and that include an emphasis on teamwork among our lawyers and other professionals and a belief in the obligation of lawyers to make legal services available to all who need them.

German Government decides on tightening the National FDI Screening Regime

By Peter Camesasca, Horst Henschen & Martin Juhasz

April 9, 2020

The German government has proposed a new draft bill reforming the current foreign direct investment (“FDI”) regime, which is likely to have a significant impact on all M&A transactions involving acquisitions of 10% or more of the voting rights in German companies active in “critical infrastructures” and “critical technologies” by any non-EU investors. Under the revised regime, such transactions will automatically be subject to a period of suspension until clearance is granted. Background Upon publishing…

Covington Competition

German Government Decides on Tightening the National FDI Screening Regime

By Peter Camesasca, Horst Henschen & Martin Juhasz

April 9, 2020

Global Policy Watch

Congressional Paper Hearings: The Future or The Past?

By Angelle Smith Baugh & Perrin Cooke

April 9, 2020

Congressional leaders are actively exploring ways to continue the work of Congress as the COVID-19 crisis continues to unfold. Currently, Congress is not able to have live, in-person hearings, which are the primary tool for conducting oversight of both the private sector and the executive branch. With existing oversight investigations still underway—and the recent establishment of both a House Select Committee on the Coronavirus Crisis and a COVID-focused Congressional Oversight Commission—leaders in both chambers…

Global Policy Watch

COVID 19 – US and EU Competition Law Implications (9 April 2020)

By Covington Team

April 9, 2020

The Covington US and EU Competition/Antitrust teams will be updating you regularly, through the Covington Competition blog, on the competition/antitrust law implications – both procedural and substantive – of the COVID-19 crisis in the US and the EU. This is our update for Thursday 9 April. Today’s new updates as compared to the previous update are highlighted – these are the headlines: Today’s EU updates: State aid development: On 9 April, the European Commission…

Covington Competition

European Commission Publishes Exceptional Antitrust Guidance for Undertakings Collaborating to Address the Shortage of Essential Products and Services during COVID-19

By Wesley Lepla, Bart Van Vooren & Loïc Waty

April 9, 2020

On 8 April 2020, the European Commission published its Communication on the “Temporary Framework for assessing antitrust issues related to business cooperation in response to situations of urgency stemming from the current COVID-19 outbreak” (the “Framework“). The Commission recognizes that supply chains have been severely disrupted due to COVID-19, combined with “an asymmetric demand shock caused by either an abrupt decline in consumer demand for certain products and services or a steep rise in demand…

Covington Competition

COVID 19 – US and EU Competition Law Implications (9 April 2020)

By Covington Competition

April 9, 2020

Inside Political Law

Congressional Paper Hearings: The Future or The Past?

By Angelle Smith Baugh & Perrin Cooke

April 9, 2020

Inside EU Life Sciences

European Commission issues Guidelines on the rational supply of medicines to avoid shortages during the COVID-19 crisis, calls for lifting export bans within the EU

By David Lorello, Bart Van Vooren & Rosa Oyarzabal

April 9, 2020

As reported previously on this blog, several member states have imposed bans, requisitioned stock and applied various other control measures on medicines and protective equipment (e.g., Belgium, Bulgaria, the Czech Republic, France, the Netherlands, and Poland). On 8 April 2020, the European Commission (“Commission”) issued Guidelines on the optimal and rational supply of medicines to avoid shortages during the COVID-19 outbreak (“Guidelines”). The Guidelines, which are not formally binding, request the Member States to…

Inside Political Law

GAO Report Reveals New Insights Into Lobbying Disclosure Act Compliance and Enforcement

By Zachary G. Parks

April 8, 2020

The 2020 annual report from the Government Accountability Office (“GAO”) provides new details regarding the state of Lobbying Disclosure Act (“LDA”) compliance and enforcement. By statute, the GAO is charged with conducting random audits of LDA compliance and submitting reports reflecting the results to Congress. This year’s audit reviewed approximately 100 quarterly “LD-2” reports filed by lobbyist employers and lobbying firms and about 160 semi-annual “LD-203” reports that disclose political contributions and politically-related contributions. Many…

Global Policy Watch

Competition law in the time of coronavirus: UK regulators’ response and approach to the COVID-19 pandemic

By James Marshall & Grace Kim

April 8, 2020

As we now enter the third week of lockdown in the UK, this blog post rounds-up the steps that the UK Competition and Markets Authority (CMA) and certain other regulators have taken to address the unprecedented challenges facing the country. This includes targeted relaxation of certain elements of the rules to facilitate essential forms of coordination, for example in relation to grocery supply, in addition to wider guidance on the CMA’s approach to enforcement in…

Covington & Burling LLP

Covington & Burling LLP Blogs

Blog Authors

German Government decides on tightening the National FDI Screening Regime

German Government Decides on Tightening the National FDI Screening Regime

Congressional Paper Hearings: The Future or The Past?

COVID 19 – US and EU Competition Law Implications (9 April 2020)

European Commission Publishes Exceptional Antitrust Guidance for Undertakings Collaborating to Address the Shortage of Essential Products and Services during COVID-19

COVID 19 – US and EU Competition Law Implications (9 April 2020)

Congressional Paper Hearings: The Future or The Past?

European Commission issues Guidelines on the rational supply of medicines to avoid shortages during the COVID-19 crisis, calls for lifting export bans within the EU

GAO Report Reveals New Insights Into Lobbying Disclosure Act Compliance and Enforcement

Competition law in the time of coronavirus: UK regulators’ response and approach to the COVID-19 pandemic

Stay Connected

Company

Support

New to the Network

Covington & Burling LLP Blogs

Blog Authors

Latest from Covington & Burling LLP